<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our aim was to describe the treatment and survival characteristics of Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WG</z:e>) in Canterbury, New Zealand </plain></SENT>
<SENT sid="1" pm="."><plain>The medical records of 48 patients diagnosed between 1 July 1997 and 31 December 2008 and fulfilling validated classification criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WG</z:e> were reviewed to characterise survivorship in the province of Canterbury, New Zealand </plain></SENT>
<SENT sid="2" pm="."><plain>The age at diagnosis was 61 years (range 20 to 83 years) with an equal number of males and females </plain></SENT>
<SENT sid="3" pm="."><plain>Using Kaplan-Meier product-limit analysis, the probability of survival at 1 and 10 years was 91% and 62% respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 12 <z:hpo ids='HP_0011420'>deaths</z:hpo> in the cohort, four occurred within 12 months of diagnosis: two from pulmonary haemorrhage and two from <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Beyond 12 months, two patients died of <z:hpo ids='HP_0000083'>renal failure</z:hpo>, two of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and one from <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo>, one from cerebrovascular disease and two from colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The median time to relapse was 6.75 years, and the probability of relapse within 10 years was 67% </plain></SENT>
<SENT sid="7" pm="."><plain>Survivorship, treatment response rate and the rate of relapse from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WG</z:e> in a cohort of patients from this high-prevalence southern hemisphere region were similar to that reported for northern hemisphere cohorts with a similar prevalence </plain></SENT>
</text></document>